Alaska Air (ALK) Warns on profits and gets a downgrade. Mush. Drops to $27.35. Down from 52-week high of $45.85.
Vion Pharmaceuticals (VION) Late-stage trial of its blood cancer drug has problems. Stock gets pounded. Down to $.85. From 52-week high of $2.30.
Northfield Labs (NFLD) Company’s red blood cell substitute PolyHeme failed to meet the primary goals of mortality and safety in a Phase III study. Shares drop to $1.86. Down from 52-week high of $17.94.
Netbank (NTBK) One analyst says company is worth nothing. It is getting close to that. Down to $.27 from 52-week high of $6.90.
Northwestern (NWEC) Energy company shares drop after the Montana Public Service Commission said it will block the sale of the company. Down to $32.97 from 52-week high of $36.66.
Douglas A. McIntyre
RSS Updates
Email Updates



